TB PHARM Flashcards

1
Q

MOA of isoniazid

A

interferes w/ mycolic acid synth. and thus disrupts cell wall synth.

  • cidal for dividing bacilli
  • static for slow growing
  • penetrates host cells-effective for intracellular bacilli
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the resistance of isoniazid

A

inability to take up the drug
alteration in target enzyme
overprod. of target enzyme
resist. emerges rapidly (never used as a single agent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

describe route of isoniazid therapy

A

rapidly absorbed from GI tract w/ oral dose

also IM injection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how does isoniazid distribute in the body?

A

all tissues & fluids (crosses the placenta, breast milk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how is isoniazid metabolized?

A

acetylated via N-acetyl transferase in liver

  • slow and fast acetylators affects therapy
  • chronic liver disease will decrease metabolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

describe the 2 major adverse effects of isoniazid therapy?

A

INH (INJURES NEURONS & HEPATOCYTES)

  1. peripheral neuropathy (competition b/w isoniazid & B6)
  2. hepatotoxicity (major problem due to toxic metabolite)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the important drug interactions to remember about isoniazid?

A
  • antacids w/ Aluminum decrease absorption

- inhibits the P450 isozyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MOA of rifampin

A

inhibits RNA synthesis by binding to beta subunit of RNA polymerase (bactericidal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

describe the resistance to rifampin

A

alteration in the beta subunit of the RNA polymerase so that it no longer binds the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

whats important to remember about the distribution of rifampin?

A

it penetrates all tissues well, including the CSF (75-80% is protein bound)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are some adverse effects of rifampin?

A

4 R’s (rna polymerase inhibitor, revs up CYP450, red body fluids, rapid resistance alone)

  1. turns body fluids orange-red
  2. GI & nervous system complaints
  3. fever, chills, aches
  4. Hepatotoxicity (jaundice occurs w/ chronic liver disease, alcoholics and elderly, more relevant in pts that are slow acetylators)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what do you have to remember about rifampin and drug interactions?

A

rifampin induces cytochrome P450

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the main therapeutic use of rifampin?

A

first line against mycobacterium tuberculosis (works on both rapidly and slowly dividing cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the most active antileprosy drug right now?

A

rifampin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MOA of ethambutol

A

disrupts cell wall synthesis by inhibiting arabinosyl transferase (enzyme used to attach mycolic acids to D-arabinose residues of arabinogalactan in peptidoglycan wall)–>increased cell wall perm.)
-may also inhibit RNA synth.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

when does ethambutol work on MTB?

A

ACTIVELY DIVIDING BACILLI

  • has static effect (possibly cidal at high levels)
  • slow development of resistance
  • no cross resistance
17
Q

describe the absorption of ethambutol

A

75% of oral dose

18
Q

What are the must know adverse effects of ethambutol?

A

ETHAMBUTOL CAUSES EYE PROBLEMS

optic neuritis (decreased visual acuity, loss of color discrimin.)
allergic reactions
hyperuricemia

19
Q

MOA of pyrazinamide

A

bacilli convert pyrazinamide to pyrazinoic acid

  • decrease pH below threshold for growth
  • resistant strains may lack the pyrazinamidase”
  • cidal or static depending on conc. in infected site
  • active against tubercle bacilli in acid environment of lysosome and mphages
20
Q

where is pyrazinamide metabolized?

21
Q

how is pyrazinamide administered?

A

orally and is rapidly absorbed from GI tract

22
Q

how is pyrazinamide distributed in body?

A

widely distributed

23
Q

what are the adverse effects of pyrazinamide?

A
  • dose related hepatotoxicity
  • mild non-gout arthralgias
  • hyperuricemia (due to inhibition of urate excretion)
24
Q

what does MDR TB refer to?

A

resistant to isoniazid and rifampin

25
MOA of cycloserine
blocks cell wall synthesis - structural analog of D-alanine - can block L-alanine racemase & D-alanine synthetase-->weak cell wall and -->cell lysis - based on concentration at the site, could be cidal or static
26
what is the indication for cycloserine?
broad spectrum, second line agent for active pulmonary and extrapulmonary TB
27
Describe the pharmacology of cycloserine
administered orally w/ good absorption | distributed widely and not protein bound
28
how is cycloserine excreted ?
excreted unchanged by kidneys
29
what are the adverse effects of cycloserine?
CNS issues - headache, tremor, vertigo, confusion, ... - contraindicated in persons w/ hx of epilepsy (EtOH increases risk for seizures)
30
what are the first-line therapy drugs for MTB?
isoniazid+rifampin+pyrazinamide+ethambutol or streptomycin
31
which pts are not recommended to take isoniazid & rifampin?
- children <2 yrs - HIV pts (taking retrovirals) - pregnant women - pts w/ LTBI w/ presumed resistance to INH or RIF
32
how is rifampin metabolized
deacetylated in liver
33
which anti-TB drug turns body fluid color to orange-red?
rifampin
34
where does pyrazinamide exert its most significant effect?
intracellular sites where MTB replicates slowly in mphages